Reported about 17 hours ago
L'Oreal has announced its acquisition of a majority stake in the British skincare brand Medik8, enhancing its presence in the dermatological market. While the financial details were not disclosed, the deal values Medik8 at approximately 1 billion euros. This strategic move is expected to bolster L'Oreal's luxury portfolio amidst slowing sales growth in its luxury division.
Source: YAHOO